Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapy.
Giannini V, Rosati S, Defeudis A, Balestra G, Vassallo L, Cappello G, Mazzetti S, De Mattia C, Rizzetto F, Torresin A, Sartore-Bianchi A, Siena S, Vanzulli A, Leone F, Zagonel V, Marsoni S, Regge D.
Giannini V, et al. Among authors: rizzetto f.
Int J Cancer. 2020 Dec 1;147(11):3215-3223. doi: 10.1002/ijc.33271. Epub 2020 Sep 14.
Int J Cancer. 2020.
PMID: 32875550
Free article.